about
The endocrine tumor summit 2008: appraising therapeutic approaches for acromegaly and carcinoid syndrome.Pegvisomant: a novel pharmacotherapy for the treatment of acromegaly.Medical therapy of acromegalyPitfalls in the diagnosis of acromegaly.Long-term monitoring of insulin-like growth factor I in adult growth hormone deficiency: a critical appraisal.The challenges of reliance on insulin-like growth factor I in monitoring disease activity in patients with acromegaly.Assessment of the magnitude of growth hormone hypersecretion in active acromegaly: reliability of different sampling models.Surgical management of acromegaly: Long term functional outcome analysis and assessment of recurrent/residual disease.Attitudes and preferences in patients with acromegaly on long-term treatment with somatostatin analogues.Discordance between growth hormone and insulin-like growth factor-1 after pituitary surgery for acromegaly: a stepwise approach and management.Good outcome following copeland hemiarthroplasty for acromegalic arthropathy.Self-perception of cognitive function among patients with active acromegaly, controlled acromegaly, and non-functional pituitary adenoma: a pilot study.Biochemical evaluation of disease activity after pituitary surgery in acromegaly: a critical analysis of patients who spontaneously change disease status.First-line octreotide-LAR therapy induces tumour shrinkage and controls hormone excess in patients with acromegaly: results from an open, prospective, multicentre trial.Treatment of acromegaly improves quality of life, measured by AcroQol.Comparison of oral glucose tolerance test (OGTT) 100 g with OGTT 75 g for evaluation of acromegalic patients and the impact of gender on test reproducibility
P2860
Q34031906-0E250C47-E9CD-4DCD-8BF2-443BBB29C15FQ35684886-54715038-8F7A-41C7-97F6-A43B4EB41785Q35895856-86AA5642-1642-451C-8B94-084B8F2FE29FQ35946611-F3D73A8B-3898-4BA3-AB4E-143E9D7552FEQ36068064-4C3E4BFB-DCEE-4654-A3D4-9D40ADF47A53Q36068074-6136FFEA-9B57-47A1-9916-D5CE42F95A7DQ36459956-1D7C7260-DDC7-49F4-AF84-47996F9772D2Q36847916-0AEF39B5-1F29-4BDD-9BE3-F63DB5C2898BQ37641076-DCEC072A-4EC2-4FA9-A006-E7DD17817BD2Q38185306-C48E2DAC-6D71-48D6-BEFE-DB86574A5D9BQ41726308-EF047BDD-9218-409E-BA43-A502FBA8CC7CQ46320272-FAD4EB0E-EEF0-46C3-BFC1-50F6C27CB7ACQ46951269-AB938549-2AB7-48C5-923E-56F534629943Q46951312-796A326D-875A-4997-BCFD-E3B9B2992788Q53189116-C7BF023A-7479-4A68-8005-73A5869D3F7AQ56962774-53C25F29-C5D5-4A39-B238-7A4F35B4BD16
P2860
description
2003 nî lūn-bûn
@nan
2003 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Long-term treatment outcome in acromegaly.
@ast
Long-term treatment outcome in acromegaly.
@en
type
label
Long-term treatment outcome in acromegaly.
@ast
Long-term treatment outcome in acromegaly.
@en
prefLabel
Long-term treatment outcome in acromegaly.
@ast
Long-term treatment outcome in acromegaly.
@en
P2093
P1476
Long-term treatment outcome in acromegaly.
@en
P2093
Holdaway IM
Rajasoorya CR
Stewart AW
P304
P356
10.1016/S1096-6374(03)00030-3
P577
2003-08-01T00:00:00Z